Alnylam Pharmaceuticals (0HD2.L) Stock Price
$463.6 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Alnylam Pharmaceuticals, AI stock picks, stock alerts and much more.
0HD2.L AI Stock Analysis
AI stock analysis for 0HD2.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Alnylam Pharmaceuticals (0HD2.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Alnylam Pharmaceuticals (0HD2.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Alnylam Pharmaceuticals (0HD2.L), currently trading at $463.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0HD2.L
-
Alnylam Pharmaceuticals, Inc.
-
Symbol
0HD2.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
60.8B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$398.5 0.5% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$136.1 1.2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.46 2.9% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.25 1.7% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.17 0.5% |
5 |
News
0HD2.L Alternative Data
Web Traffic
Alnylam Pharmaceuticals receives an estimated 56044 monthly visitors to alnylam.com.
-
Web Traffic
56044
-
Change from Previous Month
2.6%
-
3 Month Change
0.9%
-
YoY Change
0.9%
Twitter Followers
Alnylam Pharmaceuticals has 17,192 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
17192
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.7%
Facebook Engagement
Alnylam Pharmaceuticals has engaged 122 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
122
-
Daily Change
0.8%
-
1 Month Change
22.3%
-
3 Month Change
67.6%
Instagram Followers
Alnylam Pharmaceuticals has 2,144 Instagram Followers on its main Instagram account, up by 3.4% over the last month.
-
Instagram Followers
2144
-
Daily Change
0.4%
-
1 Month Change
3.4%
-
3 Month Change
9.1%
Youtube Subscribers
Alnylam Pharmaceuticals has 2,720 subscribers on its main Youtube channel, up by 0.7% over the last month.
-
Youtube Subscribers
2720
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
2.6%
Job Postings
Alnylam Pharmaceuticals currenly has an estimated 119 open job postings, up by 11.2% over the last month.
-
Job Postings
119
-
Daily Change
1.7%
-
1 Month Change
11.2%
-
3 Month Change
33.7%
Reddit Mentions
Alnylam Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
244,466 are following Alnylam Pharmaceuticals on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
244466
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
4.5%
LinkedIn Employees
According to LinkedIn, Alnylam Pharmaceuticals has 2,596 employees, up by 1.4% over the last month.
-
LinkedIn Employees
2596
-
Daily Change
1.4%
-
1 Month Change
1.4%
-
3 Month Change
2.5%
Business Outlook
According to employee reviews, the business outlook among employees at Alnylam Pharmaceuticals is 77 out of 100 (bullish).
-
Business Outlook
77
-
Change from Previous Month
0%
-
3 Month Change
1.3%
-
YoY Change
1.3%
News Mentions
Alnylam Pharmaceuticals was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0HD2.L Financials
0HD2.L Key Metrics
-
Total Revenue
$593.2M
-
Net Income
-$83.8M
-
Earnings per Share
-$0.65
-
Free cash flow
-$103.8M
-
EBITDA
-$140.8M
-
EBITDA Ratio
-0.237402
-
Total Assets
$4.3B
0HD2.L 2-year Revenue & Income
0HD2.L 2-year Free Cash Flow
0HD2.L Technicals
0HD2.L SMA
0HD2.L RSI
FAQ
What's the current price of Alnylam Pharmaceuticals (0HD2.L) Stock?
The price of an Alnylam Pharmaceuticals (0HD2.L) share is $463.6.
What's the market cap of Alnylam Pharmaceuticals?
The current market cap of Alnylam Pharmaceuticals is 60.8B.
Should I buy or sell 0HD2.L?
Multiple alternative data signals suggest that Alnylam Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Alnylam Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Alnylam Pharmaceuticals stock. The bullish indicators suggest that Alnylam Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Alnylam Pharmaceuticals (0HD2.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Alnylam Pharmaceuticals stock, given the bullish outlook.
What are some stocks similar to Alnylam Pharmaceuticals (0HD2.L) that investors often compare it to?
Alnylam Pharmaceuticals (0HD2.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Alnylam Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Alnylam Pharmaceuticals' stock price to be around $507 in 2026. Starting from the current price of $463.6, this represents a 9.4% change in price, indicating a bullish outlook for the stock.
How to buy Alnylam Pharmaceuticals (0HD2.L) Stock?
Alnylam Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Alnylam Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.